Site icon muskoka411.com

Pediatrix Acetaminophen Oral Solution For Children: Recalled Due To Risk Of Overdose

(CNW Group/Health Canada (HC))

Affected products

Product

DIN

Lot

Expiry

Pediatrix (Acetaminophen Oral Solution), 160mg/5mL

02027798

MC0079

Aug 2025

Issue

Teva Canada Ltd. is recalling one lot of Pediatrix Acetaminophen Oral Solution after routine product testing found a higher than acceptable amount of acetaminophen in the affected lot (approximately 185mg/5mL rather than the approved and labelled 160mg/5mL). This could lead to children receiving too much acetaminophen. Children may be especially at risk of the effects of acetaminophen overdose given their small size and developing bodies.

Signs of acetaminophen overdose include nausea, vomiting, lethargy, sweating, loss of appetite and pain in the upper part of the abdomen or stomach. Abdominal pain may be the first sign of liver damage and may not be apparent for 24 to 48 hours. Liver damage may result in liver failure or, in the most severe cases, death.

The product is available without a prescription and is used to relieve mild to moderate pain and fever in children from 2 to 11 years of age.

Health Canada is monitoring the company’s recall and its implementation of any necessary corrective and preventative actions. It will inform the public if any new health risks are identified.

Given the limited scope of the recall, it will not have any impact on the general availability of children’s acetaminophen products.

  What you should do
Exit mobile version